Table 3 List of approved drugs that target AGRT1, IL-6, NOS3 and TNFA.

From: Common genetic variants and pathways in diabetes and associated complications and vulnerability of populations with different ethnic origins

Gene

Action

Drug (source: DrugBank and DGIdb)

AGTR1

Antagonist

Valsartan, Olmesartan, Losartan, Candesartan cilexetil, Eprosartan, Telmisartan, Irbesartan, Azilsartan medoxomil

Agonist

Angiotensin II

NOS3

Inhibitor

Miconazole

Inducer

Levamlodipine, Pentaerythritol tetranitrate

Agonist

Levamlodipine

IL-6

Inhibitor/antibody

Tocilizumab

Antagonist/antibody

Sarilumab

TNFA

Antagonist

Glycyrrhizic acid

Inhibitor/antibody

Golimumab, Adalimumab, Etanercept, Polaprezinc, Pseudoephedrine, Pomalidomide, Amrinone, Chloroquine, Thalidomide, Infliximab

Inducer

Bryostatin 1

Neutralizer

Certolizumab pegol